Powerful Medical Receives €40 Million IPCEI Grant — read the full story

PMcardio for Individuals logo – AI ECG reader app for healthcare professionals

AI Standard in Cardiovascular Care

Trusted by 100,000+ professionals to detect heart disease quickly, accurately, and at the point of care.

Try PMcardio for Free*

* STEMI AI ECG Model (pending FDA approval) and LVEF AI ECG Model are considered investigational devices in the US. Not for clinical use.

PMcardio for Individuals mobile app showing AI ECG interpretation and STEMI detection on smartphones
How PMcardio Works

3 Steps to Instant ECG Interpretation

Snap a Photo of Any 12-lead ECG

Capture an ECG from paper, screen, or upload an image from your gallery.

Smartphone scanning a 12-lead ECG paper for instant AI interpretation with PMcardio app

Detect Over 40 ECG Conditions in Seconds

Accurately detect rhythms, STEMI and other advanced ECG abnormalities.

PMcardio app interface showing STEMI alert and detected rhythm conditions from an ECG

Visualize Results with Explainability Heatmaps

See which features matter most so you can interpret ECGs with confidence.

Explainability heatmaps in PMcardio app showing confidence levels for ECG waveform features
PMcardio Benefits

Why 100,000+ Clinicians Trust PMcardio

ECG waveform showing hidden STEMI equivalent signals detected by PMcardio

Detect Hidden STEMI Equivalents

Detect occlusive myocardial infarctions (OMIs) even without ST elevation. PMcardio’s Queen of Hearts™ AI model identifies life-threatening STEMI equivalents early.

PMcardio app screen showing AI-generated ECG heatmaps with STEMI alert

ECG AI Explainability Heatmaps (STEMI)

See why the AI flagged a result with lead-by-lead heatmaps that show which ECG features influenced the STEMI diagnosis

List of ECG diagnoses detected by PMcardio including atrial fibrillation, LBBB, and QT syndromes

36 Core Diagnoses

Covers 36 essential ECG conditions, including arrhythmias (like atrial fibrillation), conduction blocks (e.g. LBBB), heart blocks, and chamber hypertrophies.

Second Opinion Tool

Not sure if you need an emergent consult? PMcardio gives you instant, reassurance anytime, anywhere.

12 ECG Measurements

Instantly analyze heart rate, axis, P wave, PR, QRS, and QT/QTc intervals for long-term drug monitoring.

Clinically Validated in 15+ Independent Studies

Trusted by top hospitals. Backed by prospective and real-world evidence.

Join 100,000+ Clinicians Using PMcardio

PMcardio Supported Diagnoses

Diagnose up to 49 conditions, Including Critical Hidden Heart Attacks

  • Sinus bradycardia
  • Sinus rhythm
  • Sinus tachycardia
  • Paced rhythm
  • Atrial fibrillation
  • Atrial fibrillation with rapid ventricular response
  • Atrial fibrillation with slow ventricular response
  • Atrial flutter
  • Atrial flutter with rapid ventricular response
  • Atrial flutter with slow ventricular response
  • Supraventricular tachycardia
  • Suspected junctional rhythm
  • Suspected junctional bradycardia
  • Suspected accelerated junctional rhythm
  • Wide QRS rhythm
  • Idioventricular rhythm
  • Wide QRS tachycardia
  • STEMI / STEMI Equivalent
    Includes detection of STEMI equivalents (i.e. posterior STEMI, hyperacute T-waves, etc.). Negative for STEMI mimics (i.e. early repolarization, LVH, etc.).
  • 1st degree AV block
  • 2nd degree AV block, type Wenckebach
  • Higher degree AV block
  • Complete right bundle branch block
  • Incomplete right bundle branch block
  • Complete left bundle branch block
  • Incomplete left bundle branch block
  • Nonspecific intraventricular conduction delay
  • Left anterior fascicular block
  • Left posterior fascicular block
  • Bifascicular block (RBBB + LAFB)
  • Bifascicular block (RBBB + LPFB)
  • Trifascicular block (RBBB + LAFB + AVBLOCK1)
  • Trifascicular block (RBBB + LPFB + AVBLOCK1)
  • Left cardiac axis deviation
  • Right cardiac axis deviation
  • Extreme cardiac axis deviation
  • Normal axis
  • Heart rate
  • P wave
  • PR interval
  • QRS duration
  • QT interval
  • Corrected QT interval (Framingham formula)
  • RR interval
  • PP interval
  • Suspected long QT syndrome
  • Suspected short QT syndrome
  • Suspected atrial enlargement
  • Suspected ventricular hypertrophy
  • Premature complexes
Clinical Evidence

Proven Impact. Measurable Results.

See how PMcardio outperforms standard care in real clinical settings with up to 2× higher sensitivity in detecting heart attacks. Validated in 15+ external, independent studies.

Bar chart showing PMcardio’s 94% sensitivity versus 43% for standard care in detecting heart attacks
Comparison chart of rhythm condition detection: PMcardio at 95% versus standard care at 82%
Bar chart showing PMcardio’s 87% detection rate for heart blocks versus 62% with standard care
Compliance and Security

Meets Global Standards for
Safety, Privacy & Performance

PMcardio: AI-Powered ECG Interpretation

EU MDR CE Mark

PMcardio: AI-Powered ECG Interpretation

GDPR

PMcardio: AI-Powered ECG Interpretation

UK MHRA Registration

PMcardio: AI-Powered ECG Interpretation

AWS Foundational Technical Review

PMcardio: AI-Powered ECG Interpretation

ISO 13485

PMcardio: AI-Powered ECG Interpretation

MDSAP

PMcardio: AI-Powered ECG Interpretation

IEC 80001

PMcardio: AI-Powered ECG Interpretation

ISO 27001

PMcardio: AI-Powered ECG Interpretation

IEC 62304

PMcardio: AI-Powered ECG Interpretation

ISO 14971

PMcardio: AI-Powered ECG Interpretation

IEC 82304

PMcardio: AI-Powered ECG Interpretation

Plus Other Controls

Health System Implementations

Used by more than 30 EU health systems leveraging AI to streamline cardiac care and improve patient outcomes

Map showing over 30 hospitals in the US and Europe using PMcardio with performance outcomes like increased sensitivity and reduced D2B times
PMcardio for Organizations logo – AI ECG platform for healthcare institutions

Built for Healthcare Teams. Designed for Real-World Workflows.

PMcardio for Organizations brings instant AI-powered ECG analysis into your clinical systems — integrated with your EHR, optimized for fast-paced care environments, and trusted by top hospitals worldwide.

PMcardio for Organizations dashboard and mobile app displaying ECG analysis, STEMI detection, and EHR integration
PMcardio for Organizations

Transform Your Cardiology Workflow with PMcardio

Empower your institution with powerful collaboration, administration, and clinical features designed to simplify ECG management at scale. PMcardio for Organizations gives your team control, clarity, and connectivity.

Unlimited Users, Locations and Report History

Access all ECGs in your organization through a single admin dashboard.

PMcardio enterprise dashboard showing ECG reports, user info, and report filters

ECG Device Integrations & Web Platform

Integrate with ECG devices and CVIS, and efficiently administer team members and control their access permissions.

PMcardio interface shown across ECG devices, smartphones, and desktop platforms

Notifications and Care co-ordination

Ensure timely patient management through accurate cardiology consults

Critical STEMI alert notification from PMcardio on mobile phone with patient and time details

Try PMcardio for Free

Join 100,000+ clinicians already using PMcardio to detect heart conditions with AI-powered accuracy. Get instant access to PMcardio, designed for speed, simplicity, and clinical confidence.

No credit card required

5 FREE ECGs/month

Works with any 12-lead ECG image

Smiling female doctor holding a smartphone displaying the PMcardio ECG report interface

Frontlines of AI in Cardiology

Powerful Medical team receiving the MedTech Innovator 2025 Mid-Stage Grand Prize award on stage, holding a large winner’s check.

Powerful Medical Wins MedTech Innovator 2025

24. November 2025
PMcardio: AI-Powered ECG Interpretation

PMcardio Reports Positive RCT Results and Late-Breaking Clinical Science for STEMI Detection

28. October 2025
PMcardio: AI-Powered ECG Interpretation

Independent RCT and Late-Breaking Science: PMcardio to Take Center Stage at TCT 2025

6. October 2025

Prof. Marco Valgimigli, MD

Deputy Chief Cardiocentro Ticino Institute

Head of Cardiology at Cardiocentro Ticino and Principal Investigator of the TITAN-OMI randomized controlled trial. His research has shaped both European and US clinical practice guidelines on coronary stents, antithrombotic therapy, and vascular access.

Timothy D. Henry, MD

Medical Director of The Carl and Edyth Lindner Center

Leading expert in interventional cardiology and STEMI treatment. Co-founder and principal investigator of the Midwest STEMI Consortium, a registry of more than 20,000 consecutive STEMI activations. Presenting author for the TCT 2025 Late-Breaking Clinical Science on Queen of Hearts.

Matus Horvath

Head of People

Matus leads hiring strategy and culture at Powerful Medical. He previously ran the People Team at Slido, the Slovak SaaS startup later acquired by Cisco — an experience that informs how he builds a high-performing, values-driven team through rapid scaling.

Dr. Timea Kisova, MD

Clinical Research Lead

Timea leads Powerful Medical’s global external validation studies, including the multi-country AI ECG TIMI Study. With a background in biomedical sciences and a medical degree from Barts and The London School of Medicine and Dentistry, she brings the clinical discipline required to generate the prospective, real-world evidence behind every PMcardio module.

Dr. Anthony Demolder, MD, PhD

HF Pathway Lead

Research physician with a PhD on arrhythmias in heritable thoracic aortic disease. He has led international studies at the intersection of cardiology and AI — including earlier work on atrial fibrillation at AZ Sint-Jan Brugge — and now drives Powerful Medical’s heart failure pathway and LVsense™ AI model development.

Dr. Pendell Meyers, MD

ACS Pathway Lead

Emergency medicine physician, prolific educator, and Co-Editor of Dr. Smith’s ECG Blog. He is one of the leading voices behind the Occlusion Myocardial Infarction (OMI) paradigm, the clinical framework that reshaped how heart attacks are identified from the ECG — and which sits at the core of the Queen of Hearts™ model.

Adam Dej

Head of PMcardio for Organizations Engineering

Adam leads engineering for PMcardio for Organizations at Powerful Medical, driving platform architecture, backend systems, and infrastructure behind one of the company’s key growth products. He began programming at 13, entered professional IT at 17, and studied computer security at Comenius University’s Faculty of Mathematics, Physics and Informatics. Known for technical depth across distributed systems, infrastructure, and security, he builds scalable and resilient software with a sharp focus on customer impact. He also champions responsible use of AI and LLMs as force multipliers for modern engineering teams.

Gabriela Rovder Sklencarova

Head of Infrastructure

Gabriela designs the scalable, secure, distributed systems that keep PMcardio running around the clock for clinicians worldwide. She joined from Google, where she was a senior software engineer building core libraries that kept Google’s services resilient against billions of requests, and holds a BA and MA in Computer Science from the University of Cambridge.

Arezou Azar

VP Regulatory

Arezou leads Powerful Medical’s global regulatory strategy across the FDA, EU MDR, and international frameworks. She has been part of nearly every major breakthrough in AI cardiology and is an expert in US and global regulatory strategy, SaMD/digital health launches, with experience at Eko Health, Verily, AliveCor, Cardiologs, and Apple. She specializes in regulatory strategy in high-paced global organizations.

Adam Rafajdus

Head of AI

Adam grew into the Head of AI role from MLOps Engineer over six years at Powerful Medical, bringing deep expertise in deep learning and production-grade system deployment. He leads the team behind the Queen of Hearts™ AI ECG models and was awarded Best Poster at ISCE 2025 for the company’s ECG digitization pipeline.

Mike Wall

VP of Sales

Mike brings more than twenty years at UnitedHealth Group to the table, where he served health plans, employer groups, and public-sector entities as a consultative healthcare sales executive. He combines market intelligence, clinical insight, and financial acumen — the three ingredients needed to bring AI-powered diagnostics into US health systems at scale.

Amani Farid

Head of Strategic Partnerships

Amani leads partnership strategy with a hands-on approach to integration, unlocking long-term value through collaboration and scale. A University of Chicago Law School-trained attorney and former M&A and capital markets associate at two top international law firms, she brings the rare combination of legal precision and commercial execution refined across nearly a decade at Stryker and as VP of Corporate Development at RapidAI — spanning medtech, digital health, and AI-driven diagnostics.

Michal Martonak

Commercial Lead

A mathematician by training, Michal leads commercial strategy, go-to-market, and strategic partnerships with healthcare providers and clinical institutions worldwide. He previously built Powerful Medical’s data and clinical partnerships function, acquiring the large-scale clinical datasets that underpin the company’s certified AI models.

Dr. Jozef Bartunek, MD, PhD

Co-founder and VP Clinical Strategy

Interventional cardiologist and Co-director of the Cardiovascular Center in Aalst, Belgium — one of the world’s leading heart centers. A Fogarty International NIH Fellow at Harvard Medical School and visiting Professor of Medicine at Catholic University Leuven, he has authored more than 240 peer-reviewed publications in heart failure and structural heart disease, and anchors Powerful Medical’s clinical and research strategy.

Simon Rovder

Co-founder and CTO

Simon began his engineering career at Microsoft and holds a Master’s in Informatics from the University of Edinburgh. He built Powerful Medical’s technology organization from zero, scaling it to a 20+ engineer team and leading the platform architecture that powers a CE-certified Class IIb medical device used in hospitals across Europe.

Viktor Jurasek

Co-founder and CPO

Viktor has spent over a decade designing digital products across healthcare and software and has been the design and product force behind PMcardio since the first prototype. He sets the bar for how a clinical-grade product should feel in a physician’s hands — fast, clear, and trustworthy at the point of care.

Felix Bauer

Co-founder and COO

Felix studied at the Technical University of Munich and was part of the TUM Hyperloop team that repeatedly competed and won in Elon Musk’s SpaceX Hyperloop Pod Competition. He brings a rare combination of engineering rigor, regulatory discipline, and operational excellence to the company, leading operations, compliance, certification, quality management, and global market access since day one.

Dr. Robert Herman, MD, PhD

Co-founder and Chief Medical Officer

Robert is a physician-scientist, served on the Research, Digital and Innovation Committee of the European Society of Cardiology. He bridges the worlds of medicine and artificial intelligence, connecting clinicians, AI researchers, and regulators to translate algorithms into clinical practice. Forbes 30 Under 30 Europe 2024.

Martin Herman

Co-founder and CEO

Martin started coding at 14 and moved to Silicon Valley at 18, founding several companies including a US-based startup before returning to Europe with his brother Robert to build Powerful Medical. He comes from a family of doctors, which shaped his conviction that AI belongs wherever it can genuinely save lives. Forbes 30 Under 30 (Europe 2024).

Heart Attacks are #1 cause of death world-wide and killing about 12 milions people a year.

Clinical Definition of Problem

Contrary to popular belief, a heart attacks isn’t a blockage inside of the heart. A heart attack is a blockage of the coronary arteries supplying the heart muscle with oxygenated blood.

So let’s assume you get a blood clot here — it blocks the blood flow downstream, meaning the heart muscle doesn’t get oxygenated blood and heart tissue downstream starts to die.

Clinical Solution​

The way to fix it is relatively simple – doctors put in a stent that opens up the artery and renews blood flow. The latest clinical practice guidelines recommend that this “stenting” happens within 90 minutes from symptom onset.

If you don’t, even if you put in the stent in later, the heart tissue downstream has already been permanently damaged, which reduces the heart’s ability to pump blood. This is the leading cause of heart failure and increases 1-year mortality by two-fold.

Time is muscle.

You have just 90 minutes to diagnose the patient, bring them to the hospital and put in the stent, otherwise there is permanent damage. So problem is, that 1 in 2 heart attacks get initially misdiagnosed at the first point of contact.

Discover the future of medical work with us.

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.